Search Results 741-750 of 91062 for Metastasis

1. Clinical trials - Oncology (Medical)

   ... metastatic breast cancer that has progressed on treatment with everolimus in ... metastatic breast cancer after progression on previous endocrine ...

2. Paclitaxel protein-bound (intravenous route) - Mayo Clinic

   Description. Paclitaxel protein-bound injection is used to treat metastatic breast cancer (cancer that has already spread) after other treatments have ...

3. Chemotherapy For Clinical Trials - Mayo Clinic Research

   ... metastatic breast cancer patients with gBRCA 1/2 mutations. Doxorubicin ... metastatic breast cancer (TNMBC) or metastatic triple negative breast cancer.

4. Assessment of the Efficacy and Safety of Olaparib Monotherapy Versus Physicians Choice Chemotherapy in the Treatment of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations. - Mayo Clinic

   Patients with HER2 positive disease. More than 2 prior lines of chemotherapy for metastatic breast cancer. Untreated and/or uncontrolled brain metastases. Prior ...

5. A Study To Compare The Combination Of BMS-986504 With Pembrolizumab And Chemotherapy Versus Placebo Plus Pembrolizumab And Chemotherapy In First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion - Mayo Clinic

   ... Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion ... metastatic non-small cell lung cancer participants with homozygous ...

6. A Study to Evaluate MM-151, Nal-IRI, 5-FU, and Leucovorin for RAS/RAF Wild-Type Metastatic Colorectal Cancer - Mayo Clinic

   Clinical Trials · A Study to Evaluate MM-151, Nal-IRI, 5-FU, and Leucovorin for RAS/RAF Wild-Type Metastatic Colorectal Cancer · More about research at Mayo ...

7. Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advance or Metastatic Pancreatic Cancer - Mayo Clinic

   Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advance or Metastatic Pancreatic Cancer. Print ...

8. A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors - Mayo Clinic

   1 in subjects with locally advanced or metastatic synovial sarcoma (Cohort 1) or SMARCB1-null tumors (Cohort 2). Participation eligibility. Participant ...

9. Cisplatin and Gemcitabine Hydrochloride With or Without ATR Kinase Inhibitor VX-970 in Treating Patients With Metastatic Urothelial Cancer - Mayo Clinic

   Cisplatin and Gemcitabine Hydrochloride With or Without ATR Kinase Inhibitor VX-970 in Treating Patients With Metastatic Urothelial Cancer · Overview.

10. Safety and Tolerability of Atezolizumab (ATZ) in Combination With Radium-223 Dichloride (R-223-D) in Metastatic Castrate-Resistant Prostate Cancer (CRPC) Progressed Following Treatment With an Androgen Pathway Inhibitor - Mayo Clinic

    Safety and Tolerability of Atezolizumab (ATZ) in Combination With Radium-223 Dichloride (R-223-D) in Metastatic Castrate-Resistant Prostate Cancer (CRPC) ...